Telesis Bio, Formerly known as CODEX-DNA, and founded by Dan Gibson — the creator of the industry-standard Gibson Assembly® methodology, Telesis Bio offers Synthetic DNA on demand. Telesis Bio is on a mission to empower scientific researchers to rapidly and accurately write large quantities of synthetic genes. To, in effect, build biology. Telesis Bio is decentralizing DNA synthesis with the world’s most innovative portfolio of synthetic biology platform technologies. Their gene synthesis portfolio reduces the turnaround time for synthesizing biology workflows from weeks and months down to days and hours and includes the BioXp™ 3200 system (the world’s first and only gene printer), variant library services, and Gibson Assembly® reagents. In addition to automating, speeding, and optimizing DNA design and synthesis, Telesis Bio and the BioXp™ system ensure your designs stay in your hands, marrying speed and security for innovators in drug discovery, vaccine development, DNA data storage, and beyond.